organ transplant

The researchers were able to diagnose 17 patients with short telomere syndrome based on telomere length combined with targeted sequence data.

The firm said momentum from the launch of its kidney transplant test Allosure drove the overall revenue increase.

CareDx has paid Illumina a $5 million initial payment and will pay royalties in the mid-single to low-double digits on sales of future commercialized products.

The firm says its Olerup QType test is available on both Roche and Applied Biosystems platforms.

The company said it had a large uptick in testing revenues during the quarter, including for its AlloSure kidney transplant test, which was launched in October.

A King's College London-led team performed a genome-wide association study of kidney transplant donors and recipients.

Milwaukee, Wis.-based TAI Diagnostics is developing a PCR-based assay for cell-free DNA as a way to monitor the health of transplanted organs.

The firm said it expects fourth quarter revenues of $12.3 million to $12.5 million, a year-over-year increase of 13 percent to 15 percent.